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Summary Short-term memory binding is a memory function that underpins the temporary retention of 
complex objects (e.g. shapes with colours). In the verbal domain, this function has been found to be 
impaired in sporadic Alzheimer’s disease. Whether short-term memory binding is also impaired in familial 
Alzheimer’s disease, whether this impairment extends to the visual domain and whether it could be 
detected earlier than other cognitive deficits are issues yet to be investigated. Twenty two patients with 
familial Alzheimer’s disease caused by the E280A single presenilin-1 mutation, thirty carriers of the 
mutation who did not meet Alzheimer’s disease criteria (asymptomatic carriers) and 30 healthy relatives 
(non-carrier healthy controls) were assessed with a visual short-term memory task and a 
neuropsychological battery. The short-term memory task assessed the recognition of shapes, colours or 
shape-colour bindings presented in two consecutive arrays (i.e. study and test). Changes, which always 
occurred in the test array, consisted of new features replacing studied features (single feature conditions) 
or of features swapping across items (the binding condition). The neuropsychological battery comprised 
tests of associative and non-associative memory, attention, language, visuospatial and executive functions. 
Patients with Alzheimer’s disease and asymptomatic carriers performed significantly worse than healthy 
controls in the feature binding condition only. Group comparisons between asymptomatic carriers and 
healthy controls on standard neuropsychological tasks revealed no significant differences. Classification 
and area under the curve analyses confirmed that the binding task combines more sensitivity and 
specificity for patients with Alzheimer’s disease and most notably for asymptomatic carriers of the 
mutation than other traditional neuropsychological measures. This suggests that visual short-term 
memory binding deficits may be a preclinical marker for familial Alzheimer’s disease.  
Keywords: Familial Alzheimer’s disease, presenilin-1, short-term memory, memory binding, working 
memory, neuropsychological markers 
Introduction 
Memory binding is the function that supports the integration of the multiple elements of complex events 
within unified representations (von der Malsburg, 1999; Baddeley, 2000, 2007; Tulving, 2002; Zimmer et 
al., 2006). In short-term memory binding underpins the temporary retention of associations or 
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conjunctions of features (e.g. shapes with colours) as integrated complex objects (Luck and Vogel, 
1997; Treisman, 2006). In long-term memory, binding mediates the learning of associations between 
meaningful events (Baddeley, 2000; Tulving, 2002). Recent evidence suggests that retaining bindings in 
short-term memory and representing bindings as associations in long-term memory (i.e. learning) are 
functions supported by different memory processes (Colzato et al., 2006; Treisman, 2006; Logie et al., 
2009), which are also differentially affected by brain damage and by cognitive ageing (Parra et al., 
2009a, b, 2010).   
In daily living, binding on a temporary basis in short-term memory is essential to keep track of, for 
example, changing patterns of traffic while driving, or whether the white or the yellow pill has just been 
taken. Holding and updating these moment to moment changes in colour-shape binding in short-term 
memory is rather different from learning stable properties of the world such as face-name associations, or 
that the typical receptacle for mail in the UK is red and cylindrical. In the present article we focus on the 
little researched topic of short-term memory binding functions in Alzheimer’s disease and examine its 
sensitivity and specificity for familial Alzheimer’s disease.       
We recently found that the process of binding information in verbal short-term memory is impaired in 
patients with sporadic Alzheimer’s disease (Parra et al., 2009a). This finding is complementary to the 
literature on associative learning and Alzheimer’s disease, which suggests that forming associations 
between stimuli (e.g. paired associate learning) is impaired in sporadic and familial variants of the disease 
(Granholm and Butters, 1988; Buschke et al., 1999; Ardila et al., 2000; Swainson et al., 2001; Fowler et al., 
2002; Lindeboom et al., 2002; Lee et al., 2003; Gallo et al., 2004; Wang et al., 2004; Lowndes and Savage, 
2007; Lowndes et al., 2008). It had been found that patients with Alzheimer’s disease are unable to 
represent the association between objects and colours or pairs of words in verbal long-term memory 
(Buschke et al., 1999; Della Sala et al., 2000; Lloyd-Jones, 2005), or to represent in visual long-term 
memory the association between patterns and their spatial locations (Swainson et al., 2001; O'Connell et 
al., 2004).            
However, a limitation in the use of associative learning in the assessment of Alzheimer’s disease is that it 
also declines as part of normal ageing (de Jager et al., 2002, 2005; Old and Naveh-Benjamin, 2008) and in 
chronic depression (Gainotti et al., 1998; Fossati et al., 2004; Kaschel et al., 2009). This age-related long-
term memory binding decline is significantly larger than the long-term memory decline observed for the 
individual elements that compose complex events (Old and Naveh-Benjamin, 2008). Therefore, paired 
associate learning is sensitive but not specific to Alzheimer's disease. The lack of specificity of associative 
learning deficits for Alzheimer’s disease indicates that these tasks have limited potential in discriminating 
between the disease and the effects of normal ageing, and also have limited potential as prognostic 
indicators of who, among the elderly, will go on to develop the disease. Moreover, the usefulness of 
associative learning tasks to investigate memory functions in low-educated populations may encounter 
limitations (Uttl et al., 2002) even if these tasks are adapted for language requirements (Ardila et al., 1994). 
It is therefore necessary to investigate cognitive deficits that are both specific and sensitive to Alzheimer’s 
disease, independent of any contribution of other factors such as age (MacPherson et al., 2007) or 
sociocultural background. Short-term memory binding functions may therefore offer a promising 
approach.           
In contrast to associative learning, binding of visual features in short-term memory is no more affected by 
age than is memory for individual features (Brockmole et al., 2008; Parra et al., 2009b). In Alzheimer’s 
disease, binding deficits in short-term memory have been reported in the verbal domain (Parra et al., 
2009a). This deficit in Alzheimer’s disease is in addition to, but greater than, impairments in short-term 
memory for individual features. Therefore, this pattern is different from that observed in healthy older 
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adults. However, it is still unknown whether these deficits extend across modality to visual short-term 
memory. Moreover, verbal short-term memory binding deficits were observed in patients diagnosed as 
suffering from late-onset sporadic Alzheimer’s disease. It remains unknown whether they also 
characterize patients suffering from early-onset familial Alzheimer’s disease. The latter presents a 
particularly important clinical group as they permit the investigation of cognitive impairment in 
individuals who have a genetic vulnerability to developing the disease. This has clear relevance for 
investigating which cognitive impairments may be more sensitive and specific to Alzheimer’s disease in its 
early stages, or even preclinically (Ringman et al., 2009).        
If short-term memory binding deficits appear in the verbal and visual domain and are specific to both 
sporadic and familial Alzheimer’s disease, they could be proposed as a signature of Alzheimer’s disease. 
Moreover, short-term memory binding could be used to assess the development of Alzheimer’s disease in 
a way that is unaccounted for by the effects of age.       
Following these predictions, the present study investigated whether performance in a visual short-term 
memory binding task that has been shown to be insensitive to healthy ageing (Brockmole et al., 2008) was 
impaired in patients with familial Alzheimer’s disease and could also differentiate between carriers (who 
had not yet developed the disease) versus non-carriers of the mutation E280A in the presenilin-1 gene 
(Lemere et al., 1996). The presence of this mutation leads, in 100% of cases, to an autosomic dominant 
familial Alzheimer’s disease which becomes clinically detectable at, on average, ∼48 years of age 
(see Lopera et al., 1997 for a clinical description of the disease). However, early cognitive deficits have 
been reported in carriers of this gene mutation at ∼40 years of age (Lopera et al., 1997), suggesting that 
the clinical expression of this disorder may start well before it fulfils classical criteria for the diagnosis of 
Alzheimer’s disease. We hypothesized that if short-term memory binding deficits characterize Alzheimer’s 
disease regardless of the clinical form, patients with E280A-related familial Alzheimer’s disease should 
show impairment in this function. Moreover, based on previous literature on associative memory deficits 
in patients who later develop Alzheimer’s disease (Swainson et al., 2001; Fowler et al., 2002), we predicted 
that visual short-term memory binding deficits may be observed in carriers, but not in non-carriers of the 
mutation who did not yet fulfil Alzheimer’s disease criteria.  
Materials and methods 
Participant selection 
The participants selected for the present study were recruited in a large kindred from the Colombian 
province of Antioquia, South America. Members of this kindred carry a gene mutation (i.e. E280A 
of presinilin-1) that leads to early-onset familial Alzheimer’s disease in 100% of carriers (Lopera et al., 
1997). The recruitment protocol for all the participants consisted of three phases. The genetic screening, 
which was carried out using the methodology reported by the Alzheimer's Disease Collaborative Group 
(1995) (see also Lemere et al., 1996; Lendon et al., 1997), was aimed at confirming the presence of the 
mutation. Once the genotype was confirmed, the neurological and neuropsychological phases were 
performed. The results of these assessment phases allowed us to classify our research participants in three 
groups: (i) participants with early-onset familial Alzheimer’s disease caused by the E280A single presenilin-1 
mutation (early-onset familial Alzheimer’s disease carriers); (ii) carriers of the mutation who did not meet 
Alzheimer’s disease criteria (asymptomatic carriers); and (iii) healthy individuals who were not carriers of 
the gene mutation and who were relatives of members of the other two groups (non-carrier healthy 
controls).           
 Twenty-two participants were early-onset familial Alzheimer’s disease carriers, diagnosed 
according to the criteria established by the Diagnostic and Statistical Manual of Mental Disorders fourth 
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edition, text revision and the National Institute of Neurological and Communicative Disorders and Stroke 
and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) group (McKhann et 
al., 1984), and 30 were asymptomatic carriers who met neither Alzheimer’s disease nor mild cognitive 
impairment criteria (Petersen, 2004) at the time of testing but who were positive for the E280A mutation. 
Additionally, we recruited a sample of 30 non-carrier healthy controls who were relatives of early-onset 
familial Alzheimer’s disease carriers or asymptomatic carriers. The non-carrier healthy controls were 
negative for the E280A mutation and healthy according to the clinical interview and the results of the 
assessment phases described above. For both non-carrier healthy controls and asymptomatic carriers, 
additional inclusion criteria were: (i) negative history of neurological or psychiatric disorders; (ii) Mini-
Mental State Examination score ≥24; and (iii) no memory complaints as documented by a self-report and 
a family questionnaire.          
 Early-onset familial Alzheimer’s disease carriers, asymptomatic carriers and non-carrier healthy 
controls were matched according to the number of years spent in formal education (Table 1). 
Asymptomatic carriers and non-carrier healthy controls were additionally matched for the Mini-Mental 
State Examination scores. Asymptomatic carriers were significantly younger than early-onset familial 
Alzheimer’s disease carriers and healthy controls. Further analysis with subgroups matched for age 
(including age above 35: n = 17 for each of asymptomatic carriers, early-onset familial Alzheimer’s disease 
carriers and healthy controls) confirmed that age was not the factor accounting for the significant effects 
reported here (see Supplementary material). This is consistent with previous findings which demonstrate 
that age per se does not differentially affect this type of short-term memory binding processes 
(Brockmole et al., 2008; Parra et al., 2009b). All participants gave informed consent to take part in the 
study, which was approved by the relevant Ethics Committees.      
  Each participant underwent a colour vision assessment, followed by a binding 
perception condition. These conditions were undertaken to rule out the possibility that poor performance 
on the short-term memory binding task could result from visual or perceptual difficulties. Colour vision 
was initially assessed using the Dvorine pseudo-isochromatic plates (Dvorine, 1963). This test assesses 
colour vision within the red–green wavelengths. It is accepted that more than two errors suggest 
borderline or mild colour vision problems while five errors or more are indicative of colour vision 
deficits. In the present study, more than two errors were set as the exclusion criterion. Perception for 
shape-colour binding was then assessed with a task that simultaneously presented two arrays of coloured 
shapes, one in the upper half of the screen and one in the lower half. On each of 20 trials, participants 
searched for changes between the two arrays. The stimuli and design were the same as those described 
below for the shape-colour memory binding condition. The cut-off score, which indicates perceptual 
binding difficulties, was set at 90% correct (18 out of 20 trials). None of the participants recruited for the 
present study were excluded due to colour vision or perceptual binding problems. The demographic 
characteristics of the three groups of participants are shown in Table 1.  
Assessment 
The assessment consisted of two parts: a neuropsychological battery and a short-term memory task. The 
neuropsychological battery comprised the Mini-Mental State Examination (Folstein et al., 1975), the 
Paired Associates Learning Task (Wechsler, 1945), Spanish versions of Verbal Fluency Tests (Letters-
FAS, adapted from Sumerall et al., 1997; and Animals), the Copy and Recall of the Complex Figure of 
Rey–Osterrieth (Osterrieth 1944; Rey, 1941), Part A of the Trail Making Test (Reitan, 1958) and the 
Wisconsin Card Sorting Test (Berg, 1948).        
 The short-term memory task was similar to that reported in Brockmole et al.’s Experiment 2 
(2008). The task assessed visual short-term memory for arrays of stimuli presented on a computer screen. 
Stimuli were shapes (six-sided random polygons as shown in Fig. 1A), colours, or combinations of shapes 
and colours. Stimuli were randomly selected from a set of eight shapes and a set of eight colours and were 
5  
 
presented either independently (i.e. visual short-term memory for single features) or combined (i.e. visual 
short-term memory binding). Each type of stimulus was presented in a separate condition.  
 During the task, asymptomatic carriers and healthy controls were presented with arrays of three 
items while early-onset familial Alzheimer’s disease carriers were presented with arrays of two items. 
Previous pilot studies suggested that these memory loads would allow performance levels in memory for 
single features to be equated across groups while keeping the early-onset familial Alzheimer’s disease 
carriers’ performance above floor and the controls’ performance below ceiling. This follows our standard 
procedures (Logie et al., 2004, 2007; Parra et al., 2009a, b) for comparing the impact of experimental 
manipulations on patients and controls. In the present experiment, it ensures that any differences between 
groups on visual short-term memory binding performance can be attributed to the binding requirement 
and cannot be attributed to baseline differences in memory for single features.    
 The trial design for each condition of the visual short-term memory task is shown in Fig. 1B. The 
task was based on a change detection paradigm. At the beginning there was a fixation screen for 500 ms. 
This was followed by the study display which was presented for 2000 ms. The study display presented two 
or three items as explained above. The task for the participant was to remember these items. After the 
study display there was an unfilled retention interval of 900 ms which was followed by the test display. 
The participants were asked to recognize if the items presented in the test display were the same or 
different from those presented at study. In 50% of the trials, the items were the same in both displays (i.e. 
‘same trials’). In the other 50%, two items in the test display were different (i.e. ‘different trials’).  
 Two conditions assessed visual short-term memory for single features and one assessed the 
binding of these features in visual short-term memory. In the ‘shape only’ and ‘colour only’ conditions, 
arrays of shapes (Fig. 1A) or colours were presented in the study display. In the test display for the 
‘different trials’, two new shapes or new colours from the study array were replaced with two new shapes 
or two new colours. Hence, in these conditions, only visual short-term memory for individual features 
was required to detect a change. In the shape-colour binding condition, combinations of shapes and 
colours were presented in the study display. In the test display for the ‘different trials’, two shapes 
swapped the colours in which they had been shown in the study display. Hence, memory for bindings of 
shape and colour in the study display was required in order to detect this change. No shape or colour was 
repeated within a given array. Each condition consisted of 15 practice trials followed by 32 test trials. Out 
of 32, 16 were ‘same trials’ (the study and test displays presented identical items) and 16 were ‘different 
trials’ (Fig. 1B). The task for the participants was to detect when a change had occurred and to respond 
orally ‘same’ or ‘different’ as appropriate. The experimenter entered participants’ responses using the 
keyboard. Trials were fully randomized across participants and conditions were delivered in a 
counterbalanced order.  
Statistical analysis 
The scores on the neuropsychological battery were compared across groups using one-way ANOVA 
followed by Bonferroni-corrected post hoc tests (Table 1). For the visual short-term memory task, 
performance of early-onset familial Alzheimer’s disease carriers with two items and of healthy controls 
and asymptomatic carriers with three items were compared using a two-way mixed ANOVA model. This 
manipulation was aimed at equating performance across groups in conditions assessing short-term 
memory for single features. Hence, it permitted the investigation of whether visual short-term memory 
binding deficits are specific to early-onset familial Alzheimer’s disease and cannot be explained by the task 
demands of remembering individual features. The between-subjects factor was group (healthy controls 
versus asymptomatic carriers versus early-onset familial Alzheimer’s disease carriers) and the within-
subjects factor was condition (shape only versus colour only versus shape-colour binding). Post hoc 
comparisons were carried out across groups for each condition separately (3 × 3 = 9 contrasts) and across 
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conditions for each group separately (3 × 3 = 9 contrasts). With a total of 18 pairwise comparisons, the 
Bonferroni corrected alpha level was set at 0.003. For the main effects in the short-term memory task, the 
effects size (γ) and power (Pw) were calculated (Cohen, 1988). The effect size was defined as the square 
root of the proportion of the total variance attributed to an effect [γ = Sqrt(Eta)] (Leech et al., 2007). 
According to Cohen’s (1988) criteria, Sqrt(Eta) values >0.24 represent medium effect sizes and >0.31 
represent large effect sizes. Two dependent variables were calculated: percentage of correct recognition 
and sensitivity for change detection (Stanislaw and Todorov, 1999). The percentage of correct recognition 
was defined as the proportion of trials correctly performed (i.e. hits for different trials and correct 
rejections for same trials) out of 32 per condition, expressed as a percentage. Additionally, we 
implemented the calculation of the Signal Detection Theory (Stanislaw and Todorov, 1999). We chose A′ 
(Pollack and Norman, 1964) as the sensitivity measure, since this has been suggested to be a valid 
measure of performance in change detection tasks as it does not have indeterminacy when a participant 
does not make false alarms. The information provided by A′ is complementary to that obtained from the 
Percentage of correct recognition as it provides information on the ability to extract the signal (i.e. 
changing items) from the noise (i.e. distractors). Therefore, if poor performance (i.e. low Percentage of 
correct recognition) is accounted for by low A′ (sensitivity), this would suggest that the memory 
impairment is due to difficulties in keeping separate in memory the signal from the noise (see Xu, 2002 
for the formula used).           
 The percentage of correct recognition was chosen to perform further classification analysis. This 
was aimed at investigating the accuracy of the neuropsychological and visual short-term memory variables 
to detect impaired performance at an individual level. To this aim, standard neuropsychological scores 
(mean ± 2 SD) obtained from the same or similar Spanish speaking populations (Ardila et al., 1994) were 
used as cut-off. In the case of the short-term memory tasks, the standard values were obtained from the 
controls recruited for the present study. In order to control for outliers in the healthy controls group we 
performed a test for outlier detection (Barnett et al., 1994; see Supplementary material for the results of 
this analysis). The number of participants that performed below the cut-off was determined. Contingency 
tables were then constructed to compare, using chi-square analysis, the proportion of participants that 
were classified as below or above cut-off within each group for each dependent variable. Finally, area 
under the curve analysis was performed to investigate the sensitivity and specificity of the 
neuropsychological and short-term memory variables to classify the participants correctly. The sensitivity, 
specificity, positive predictive value (PPV) and negative predictive value (NPV) were calculated.  
Results 
Neuropsychological assessment 
The results of the neuropsychological assessment are presented in Table 1. Comparisons carried out 
across groups revealed that early-onset familial Alzheimer’s disease carriers had poorer memory 
performance than both healthy controls and asymptomatic carriers in the Paired Associates Learning task 
(Wechsler, 1945) and in the Recall of the Rey–Osterrieth Complex Figure (Rey, 1941; Osterrieth, 1944). 
Executive and attention functions were also significantly worse in early-onset familial Alzheimer’s disease 
carriers than in healthy controls and asymptomatic carriers as assessed by the Verbal Fluency Tests 
(Letters-FAS and Animals), the Wisconsin Card Sorting Test (Berg, 1948) and the Trail Making Test 
(Reitan, 1958). These neuropsychological findings suggest that early-onset familial Alzheimer’s disease 
carriers presented with an amnesic and dysexecutive syndrome resembling the behavioural pattern 
described for sporadic Alzheimer’s disease (Greene et al., 1995). Finally, mean performance of healthy 
controls and asymptomatic carriers did not significantly differ on any of the neuropsychological test 
scores.  
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Short-term memory task 
ANOVA with percentage of correct recognition 
Significant main effects were found for Group [F(2,79) = 7.6, P = 0.001; γ = 0.40, Pw = 94], Condition 
[F(2,158) = 282.9, P < 0.001; γ = 0.88, Pw = 100] and for the interaction of Group × Condition 
[F(4,158) = 14.86, P < 0.001; γ = 0.52, Pw = 100] (Fig. 2A).  
Post hoc comparisons following the significant interaction showed that early-onset familial Alzheimer’s 
disease carriers, asymptomatic carriers and healthy controls did not differ significantly in memory 
performance on the shape only or colour only conditions. Early-onset familial Alzheimer’s disease carriers 
performed significantly more poorly than healthy controls (but not than asymptomatic carriers) in the 
condition assessing memory for shape-colour binding [mean difference (MD) = 18.04, standard error 
(SE) = 2.97, P < 0.001]. Asymptomatic carriers also performed more poorly than healthy controls in the 
condition assessing memory for shape-colour binding (MD = 12.63, SE = 2.73, P < 0.001).   
 The analysis across conditions showed that for both early-onset familial Alzheimer’s disease 
carriers and asymptomatic carriers, performance was in the following format: memory for shape-colour 
binding < memory for shape only < memory for colour only (all the comparisons were significant at P  
< 0.001). For the healthy controls, performance was in the form of: (memory for shape-colour 
binding = memory for shape only) < memory for colour only. These results suggest that when shape-
colour bindings were to be retained in visual short-term memory, early-onset familial Alzheimer’s disease 
carriers and asymptomatic carriers performed alike and both were significantly worse than healthy 
controls’ scores.  
ANOVA with A′  data 
A significant main effect was found for Group [F(2,79) = 11.34, P < 0.001; γ = 0.47, Pw = 99]. The 
assumption of homogeneity of variance and covariance was violated for the factor condition 
[Mauchly’s W (2) = 0.56, P  < 0.001]. Hence, we corrected the degrees of freedom using the Greenhouse–
Geisser epsilon (0.694). After applying this correction factor, significant main effects were also found for 
Condition [F(1.38, 109.65) = 147.34, P < 0.001; γ = 0.81, Pw = 100] and for the interaction of Group by 
Condition [F(2.77, 109.65) = 17.12, P < 0.001; γ = 0.55, Pw = 100] (Fig. 2B).    
 Post hoc comparisons carried out across groups showed that early-onset familial Alzheimer’s 
disease carriers, asymptomatic carriers and healthy controls did not show significant differences in 
sensitivity in any of the contrasts performed in the conditions assessing memory for shape only or colour 
only. Early-onset familial Alzheimer’s disease carriers proved to be significantly less sensitive than healthy 
controls to detect changes in the condition assessing memory for shape-colour binding (MD = 0.22, 
SE = 0.04, P < 0.001). No other contrast performed across groups in the condition assessing memory for 
shape-colour binding resulted in significant effects.       
 The analysis across conditions showed that the pattern of sensitivity in early-onset familial 
Alzheimer’s disease carriers and asymptomatic carriers was in the following format: memory for shape-
colour binding < shape only < memory for colour only (all the comparisons were significant at P < 0.001 
except for the contrast between shape and colour only in patients with early-onset familial Alzheimer’s 
disease in which P = 0.003). For healthy controls the pattern of sensitivity was in the form of (memory 
for shape-colour binding = memory for shape only) < memory for colour only.  
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Classification analysis 
Classification analysis was carried out to investigate whether the group effects described above were 
representative of performance of each individual within the three groups. Table 2 shows the results of 
this analysis. When the number of asymptomatic carriers and healthy controls performing below cut-off 
in the neuropsychological tasks was entered into contingency tables analyses, the proportion of 
participants that performed below cut-off was small and did not significantly differ across groups (except 
for the Recall of the Rey Figure in which more asymptomatic carriers performed below cut-off). A 
significantly larger proportion of early-onset familial Alzheimer’s disease carriers performed below cut-off 
in almost all the neuropsychological tasks as compared to asymptomatic carriers and healthy controls. The 
Copy of the Rey Figure was the only task in which the proportion of asymptomatic carriers and early-
onset familial Alzheimer’s disease carriers performing below cut-off was not significantly different.  
 The analysis of the visual short-term memory variables revealed that the proportion of 
asymptomatic carriers and early-onset familial Alzheimer’s disease carriers performing below cut-off in 
the condition assessing shape-colour binding was significantly larger than the proportion of healthy 
controls (none of the participants from this last group fulfilled outlier criteria, see Supplementary 
material). The proportions for the first two groups did not differ significantly. No other contrast 
performed with this task resulted in significant effects. These results suggest that the group effects 
described above are representative of performance of a large proportion of participants within each group 
of carriers of the E280A mutation and support the usefulness of the short-term memory task presented 
here in detecting significant deficits on an individual level. This may have important implications for the 
use of this task within clinical settings.        
 Finally, performance on the Paired Associates Learning task, Recall of the Rey–Osterrieth 
Complex Figure and the shape-colour binding condition were chosen for area under the curve analysis as 
these were the tasks in which the most asymptomatic carriers and early-onset familial Alzheimer’s disease 
carriers were found to be impaired (Table 2). Figure 3A–C shows the results of the analysis. The task 
assessing short-term memory for shape-colour binding proved to be sensitive for detecting both early-
onset familial Alzheimer’s disease carriers (sensitivity = 77%, PPV = 77%, NPV = 83%) and 
asymptomatic carriers (sensitivity = 73%, PPV = 81%, NPV = 76%) and for separating them from 
healthy controls (specificity = 83%). The Paired Associates Learning task proved sensitive for detecting 
patients with early-onset familial Alzheimer’s disease (sensitivity = 82%, PPV = 72%, NPV = 85%) but 
much less so for detecting asymptomatic carriers (sensitivity = 40%, PPV = 63%, NPV = 56%). This task 
was also a little less specific than the short-term memory binding task (specificity = 77%). In the case for 
the Recall of the Rey–Osterrieth Complex Figure, this task proved insensitive to detect asymptomatic 
carriers (sensitivity = 23.3%, PPV = 86%, NPV = 55%) but more sensitive to detect early-onset familial 
Alzheimer’s disease carriers (sensitivity = 77%, PPV = 94%, NPV = 85%). This task however, showed 
high specificity (96%).  
Discussion 
The results showed a clear impairment in visual short-term memory binding in both early-onset familial 
Alzheimer’s disease carriers and asymptomatic carriers of the mutation. These results cannot be 
accounted for by differences between groups in general memory capacity, since memory performance on 
the single feature conditions was equated across the three groups. Logie et al. (2004, 2007) and Parra et al. 
(2009a) used a similar methodology for comparing the impact of experimental manipulations on patients 
and controls. For example, Logie et al. (2004, 2007) asked their participants to perform two concurrent 
tasks each titrated to the individuals (i.e. by using their own span). Thereby any cost found during the 
concurrent condition could not be attributed to the demands of each task. Parra et al. (2009a) were able to 
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compare performance of patients with Alzheimer’s disease and controls by altering the number of to be 
remembered items in the baseline (single feature) condition to equate performance between groups. In 
the current study this methodology enabled the investigation of binding functions in visual short-term 
memory once baseline differences due to memory for single features were controlled. This technique also 
avoided floor effects in the patient groups and ceiling effects in the controls.   
 Healthy controls performed the memory binding condition as well as they performed the 
condition assessing memory for shapes only, indicating that memory binding was not more demanding 
than the shape only condition. Furthermore, this suggests that healthy individuals can represent in visual 
short-term memory the shapes and colours used in this task as integrated units (Luck and Vogel 
1997; Wheeler and Treisman 2002; Brockmole et al., 2008). Therefore, the results presented here suggest a 
differential and specific impairment in visual short-term memory binding in early-onset familial 
Alzheimer’s disease carriers and asymptomatic carriers of this mutation who have not yet developed the 
disease. This impairment is characterized by a loss of the ability to represent objects integrated as a whole 
in visual short-term memory.         
 Additionally, the results from the current study, in which the visual recognition of features was 
assessed, together with those from previous studies using free recall of verbal features (Parra et al., 2009a), 
suggest that short-term memory binding deficits in Alzheimer’s disease do not seem to be restricted to 
specific types of information (visual and verbal stimuli) or to a specific retrieval process (recall and 
recognition).          
 Asymptomatic carriers remembered shapes only or colours only no differently from the healthy 
controls. However, they could not remember the temporary binding between these features to the same 
extent as the controls. The analyses across conditions showed that early-onset familial Alzheimer’s disease 
carriers and asymptomatic carriers performed similarly with poorer performance on memory for binding 
than in both memory for single feature conditions. This contrasted with controls’ performance in which 
memory for binding and memory for shape did not differ. For early-onset familial Alzheimer’s disease 
carriers (but not for asymptomatic carriers), low sensitivity for change detection (A′) accounted for poor 
memory performance. This suggests that as the disease progresses, the mechanisms underpinning 
memory deterioration also change. Even though asymptomatic carriers were able to keep separate in 
short-term memory the signal from the noise during recognition of changes, they were less able to retain 
information from the signal only in the condition where different pieces of information had to be bound 
together (i.e. shape-colour binding).         
 It is striking that, despite the impairment in visual short-term memory binding shown by 
asymptomatic carriers, group comparisons revealed that asymptomatic carriers and healthy controls did 
not differ significantly in scores on any of the standard neuropsychological tasks and both were 
significantly different from early-onset familial Alzheimer’s disease carriers in tasks assessing general 
memory, executive and attention functions. Classification analysis showed that more asymptomatic 
carriers were impaired than healthy controls on only one standard memory measure, Recall of the Rey 
Figure. However, as the classification analysis showed, this test did not combine sensitivity with 
specificity for asymptomatic carriers. The classification analyses also confirmed that the results obtained 
with group comparisons were accounted for by performance of the majority of the participants recruited 
within each group.           
 Of note, the Paired Associates Learning task and the shape-colour binding were the two tasks in 
which the most asymptomatic carriers and early-onset familial Alzheimer’s disease carriers performed 
below cut-off. This is in keeping with the literature on associative memory and Alzheimer’s disease which 
suggests that in the course of the disease, these forms of memory seem to deteriorate earlier and deficits 
are more pronounced than for non-associative memory (Granholm and Butters 1988; Buschke et al., 
1999; Swainson et al., 2001; Fowler et al., 2002; Lindeboom et al., 2002; Lee et al., 2003; Gallo et al., 
2004; Lowndes and Savage 2007; Lowndes et al., 2008). For example, in the study by Fowler et al. (2002), 
the authors assessed a group of individuals at risk for developing sporadic Alzheimer's disease (i.e. 
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patients with mild cognitive impairment) with the Cambridge Neuropsychological Test Automated 
Battery Paired Associates Learning test. They found that those who performed poorly on this test at 
baseline were more likely to convert to Alzheimer’s disease in 24 months of follow-up (see 
also Swainson et al., 2001; O'Connell et al., 2004). However, the actual contribution of the Paired 
Associates Learning test to determine who, among the elderly, can deviate from the course of normal 
ageing and go on to develop Alzheimer’s disease remains unclear because this test is sensitive to the 
effects of age (see de Jager et al., 2002, 2005). This is not the case for the short-term memory binding task 
presented here which has proved insensitive to the effects of normal ageing (Brockmole et al., 2008; 
see Supplementary material for further analysis with age of the current data). If we were to assume that 
the asymptomatic carriers assessed here are at an equivalent point in the course of the disease as 
individuals with pre-mild cognitive impairment progressing to sporadic Alzheimer’s disease, we would 
propose that the short-term memory binding task may be useful for detecting cognitive changes in this at 
risk population. In fact, Lopera et al. (1997) described that E280A-related Alzheimer’s disease resembles 
phenotypically sporadic Alzheimer’s disease in almost all its features. However, the results from other 
studies suggest that there may be phenotypic differences across genetic and sporadic Alzheimer’s disease 
(Holmes, 2002; Mosconi et al., 2003). Even mutations of the same gene (i.e. presenilin-1) may lead to 
different phenotypes. Ringman et al. (2005) assessed a sample of young carriers (average age 28.9) of the 
mutation A431E of the presenilin-1 gene, which leads to early-onset familial Alzheimer’s disease. They 
showed significant neuropsychological impairments. The carriers of the mutation E280A of the presenilin-1 
gene assessed in the present study were, as a group, older than those assessed by Ringman et al. (2005). 
However, they were asymptomatic. Therefore, the extent to which findings in genetic Alzheimer’s disease 
could be used to predict changes in sporadic Alzheimer’s disease and vice versa, still requires more 
investigation.     
The relationship between neuroanatomical damage in Alzheimer’s disease and associative learning deficits 
has been well established. There is a great deal of evidence supporting the role of the hippocampus in 
associative learning (Mayes et al., 2007). The high sensitivity of the Paired Associates Learning task to 
Alzheimer’s disease has been linked to early damage to the hippocampus (Mayes et al., 2007; Lowndes et 
al., 2008). Short-term memory binding also implies association. However, there is evidence suggesting 
that inter-item associations (i.e. items-locations as in the Paired Associates Learning task) and intra-item 
associations (i.e. shapes-colours as in the current short-term memory binding task) are functions 
supported by different brain regions (Piekema et al., 2006, see also Mayes et al., 2004 for the case YR). The 
fact that the visual short-term memory binding task presented here has proved insensitive to the effects 
of age can be explained by these earlier observations. As shape-colour binding does not require the 
hippocampus, this test may be less sensitive to normal ageing, as older adults show some degree of 
hippocampal atrophy (Grady et al., 2003; Grady 2008). However, shape-colour binding does require 
effective brain connectivity (Zimmer et al., 2006). The Alzheimer’s disease pathology is characterized by a 
predominant disconnection. It might be possible that, using appropriate tests, this disconnecting process 
could be detected earlier than other structural damage resulting from neural death (i.e. hippocampal 
atrophy). This proposal may suit recent reports (Bates, 2009) which suggest that future cognitive markers 
for Alzheimer’s disease should detect the diseases in stages before substantial neuronal cell loss has 
occurred.            In 
the present study we found that the Paired Associates Learning task (Wechsler, 1945) was the 
neuropsychological task in which the largest number of healthy controls performed below cut-off. This 
may have negative implications for the use of verbal associative learning tasks to investigate low educated 
populations (Ardila et al., 1994). The observation that fewer healthy controls performed below cut-off in 
the short-term memory task supports the usefulness of tests with low verbal demands to assess such 
populations. Other tasks that have proved sensitive for detecting cognitive changes in patients with mild 
cognitive impairment are the visual delayed matching-to-sample task (Barbeau et al., 2004) and The 
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Montreal Cognitive Assessment (Nasreddine et al., 2005). The Montreal Cognitive Assessment yielded 
sensitivity of 90 and 100% for mild cognitive impairment and Alzheimer’s disease, respectively, while its 
specificity was 87%. These tasks may however be performed poorly by low-educated population as they 
pose high-semantic demands. A further limitation of the current tests used to detect Alzheimer’s disease 
is that they are also performed poorly by some healthy older adults. The format of the Montreal Cognitive 
Assessment is similar to that of the Mini-Mental State Examination. Ardila et al. (1994) suggested 23 
points as the appropriate Mini-Mental State Examination cut-off score for subjects with minimal 
education. This suggests that even if these tasks were standardized in this population, their outcomes 
would be influenced by this sociodemographic factor. The task presented here has the advantage that its 
outcomes are unaccounted for by the effects of age (Brockmole et al., 2008) or low sociocultural 
background.  
Both the Paired Associates Learning task and the short-term memory task showed high sensitivity and 
specificity at detecting early-onset familial Alzheimer’s disease carriers. However, the short-term memory 
binding task investigated here was much more sensitive than was the Paired Associates Learning at 
detecting asymptomatic carriers who had not yet developed the disease. Even though the Recall of the 
Rey–Osterrieth Complex Figure proved specific, its sensitivity for both asymptomatic carriers and early-
onset familial Alzheimer’s disease carriers was very low. This suggests that in the course of developing 
E280A-related familial Alzheimer’s disease, visual short-term memory binding deficits can be detected 
much earlier than impairments of other functions, including associative learning, which are assessed by 
traditional neuropsychological tasks. Ringman et al. (2009) suggest that the study of familial Alzheimer’s 
disease provides an opportunity to test various criteria for early Alzheimer’s disease. The results of the 
present study support this statement and suggest that short-term memory binding functions may form 
part of the assessment criteria for early Alzheimer’s disease.      
 In summary, we have found that visual short-term memory binding is affected in E280A-related 
familial Alzheimer’s disease. Notably impairments of this function were also observed in carriers of the 
mutation who were asymptomatic on standard neuropsychological tests. These results suggest that short-
term memory binding deficits are a fundamental feature of Alzheimer’s disease and may be a pre-clinical 
marker for early-onset E280A familial Alzheimer’s disease in carriers of the mutation. It is also possible 
that the short-term memory binding deficit reflects the presence of the gene mutation/phenotype and 
that this gene mutation also leads in 100% of cases to conversion to Alzheimer’s disease in early middle 
age. However, since similar short-term memory binding deficits have also been found in late-onset 
sporadic Alzheimer’s disease these results raise the question as to whether these deficits might also prove 
to be a preclinical marker for all forms of the disease. Future studies should investigate this hypothesis 
with short-term memory binding tasks that have proved insensitive to the effects of normal ageing, highly 
sensitive to the effects of Alzheimer’s disease and are able to detect the development of genetic variant of 
the disease much earlier than other traditional cognitive procedures.  
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Tables and Figures  
Table 1. Demographic and neuropsychological data for the three groups of participants 
 
a Asymptomatic carriers versus non-carrier healthy controls different at P < 0.05.  
b Asymptomatic carriers versus early-onset familial Alzheimer’s disease carriers different at P < 0.05   
c Non-carrier healthy controls versus early-onset familial Alzheimer’s disease carriers different at P < 0.05.  
E-FAD = early-onset familial Alzheimer’s disease carriers. 
  
Healthy 
controls 
(n = 30) 
Asymptomatic 
carriers 
(n = 30) 
E-FAD carriers 
(n = 22) One-way ANOVA 
              F(P) Post hoc tests (P-value) 
  Mean 
(SD) Range 
Mean 
(SD) Range 
Mean 
(SD) Range   
Asymptomatic 
Carriers 
versus 
Healthy 
Controls 
Asymptomatic 
Carriers 
versus E-FAD 
Healthy 
controls 
versus 
E-FAD 
Agea,b 40.9 (9.3) 
(24–
58) 
35.6 
(6.6) 
(23–
46) 
45.2 
(4.8) 
(32–
52) 
11.2 
(0.000) 0.018 0.001 0.12 
Years of 
education 
9.5 
(3.2) 
(4–
16) 
9.3 
(4.4) 
(1–
20) 
8.5 
(4.2) 
(1–
18) 
0.5 
(0.60) 1 1 0.98 
Mini-Mental 
State 
Examinationb,c 
29.4 
(1.3) 
(24–
30) 
29.2 
(1.3) 
(25–
30) 
25.5 
(3.7) 
(18–
30) 
23.76 
(0.000) 1 0 0 
Paired 
Associates 
Learningb,c 
13.1 
(3.5) 
(6–
19) 
12.1 
(4.0) 
(5–
20) 
7.4 
(3.5) 
(3–
16) 
15.84 
(0.000) 1 0 0 
Verbal 
Fluency 
(Letters-
FAS)b,c 
12.4 
(3.6) 
(6–
19) 
11.5 
(5.8) 
(2–
29) 
8.4 
(3.6) 
(3–
16) 
5.217 
(0.007) 1 0.04 0.007 
Verbal 
Fluency 
(Animals)b,c 
20.5 
(4.1) 
(12–
28) 
18.6 
(5.3) 
(9–
32) 
14.1 
(3.6) 
(9–
21) 
13.27 
(0.000) 0.33 0.002 0 
REY-Copyc 27.5 (4.7) 
(19–
34) 
24.2 
(7.0) 
(4–
34) 
21.1 
(7.8) 
(3–
31) 
6.11 
(0.003) 0.15 0.32 0.003 
REY-Recallb,c 16.3 (6.1) 
(4–
26) 
13.2 
(6.6) 
(3–
26) 
4.0 
(4.3) 
(0–
19) 
28.85 
(0.000) 0.17 0 0 
Trail Making 
Testb,c 
61.7 
(26.5) 
(17–
138) 
73.7 
(52.2) 
(31–
290) 
114.76 
(61.08) 
(39–
275) 
9.66 
(0.000) 1 0.004 0 
Wisconsin 
Card Sorting 
Test 
Categoriesb,c 
3.5 
(1.5) (1–6) 
3.3 
(1.5) (0–6) 
1.6 
(1.0) (0–3) 
13.29 
(0.000) 1 0 0 
Wisconsin 
Card Sorting 
Test 
Conceptb,c 
11.7 
(7.0) 
(6–
31) 
11.4 
(7.4) 
(2–
37) 
21.7 
(17.5) 
(6–
46) 
6.91 
(0.002) 1 0.004 0.005 
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Figure 1. (A) Shapes used to construct stimuli arrays. (B) Experimental conditions and trial designs. 
 
 
 
Figure 2. (A) Percentage of correct recognition and (B) sensitivity (A′) in non-carrier healthy controls, 
asymptomatic carriers and early-onset familial Alzheimer’s disease carriers (E-FAD) in the short-term 
memory task (error bars represent the standard errors of the mean). 
 
 
 
 
17  
 
Table 2. Results of the classification analysis carried out for each variable at individual level 
Cut-off score Number performing below cut-off Chi-square analysis X
2 (P) 
  
    
Healthy 
controls 
(out of 
30) 
Asymptomatic 
carriers (out 
of 30) 
E-FAD 
carriers 
(out of 
22) 
Asymptomatic 
carriers versus 
healthy 
controls 
Asymptomatic 
carriers versus 
E-FAD 
Healthy 
controls 
versus E-
FAD 
Shape onlya 78 3 7 5 1.92 (0.17) 0.002 (0.99) 1.58 (0.21) 
Colour onlya 90.9 3 2 5 0.218 (0.64) 2.81 (0.09) 1.58 (0.21) 
Shape-colour 
bindinga 73.6 5 22 17 19.5 (0.00) 0.105 (0.75) 19.1 (0.00) 
Mini-Mental 
State 
Examinationb 
28.7 3 4 16 0.162 (0.69) 18.9 (0.00) 21.5 (0.00) 
Paired 
Associates 
Learningc 
11 7 12 18 1.93 (0.17) 9.09 (0.00) 17.4 (0.00) 
Verbal 
Fluency 
(Letters-
FAS)b 
7 1 4 9 1.96 (0.16) 5.15 (0.02) 11.5 (0.00) 
Verbal 
Fluency 
(Animals)b 
14.4 2 6 13 2.31 (0.13) 8.36 (0.00) 4.14 (0.04) 
REY-Copyb 19 1 5 8 2.96 (0.08) 2.63 (0.11) 9.68 (0.00) 
REY-Recallb 6 1 6 17 4.04 (0.04) 16.9 (0.00) 30.7 (0.00) 
Trail Making 
Testb 114 2 4 8 0.741 (0.40) 3.79 (0.05) 7.21 (0.01) 
Wisconsin 
Card Sorting 
Test 
Categoriesb 
2 2 2 11 0 (1) 12.7 (0.00) 12.7 (0.00) 
Wisconsin 
Card Sorting 
Test 
Conceptb 
21 3 4 9 0.162 (0.69) 5.15 (0.02) 6.83 (0.01) 
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E-FAD = early-onset familial Alzheimer’s disease carriers. X2 (P) = chi-square and associated P-value   
a The cut-off scores were obtained from non-carrier healthy controls.  
b The cut-off scores correspond to the norms (M ± 2 SD) obtained from the same population.  
c The cut-off score corresponds to the norms (M ± 2 SD) obtained from a Spanish speaking population 
(Ardila et al., 1994).  
 
Figure 3. Area under the curve analysis with asymptomatic carriers’ and early-onset familial Alzheimer’s 
disease carriers’ (E-FAD) performance on the (A) shape-colour binding condition of the visual short-term 
memory task, on the (B) Paired Associates Learning (PAL) task from the Wechsler Memory Scale, and on 
the (C) Recall of the Rey–Osterrieth Complex Figure. 
 
 
